• Responsible for driving country medical activities in alignment with regional initiatives and the Global Medical Plan • Proactively manage medical scientific stakeholders and create value for patients through medical and scientific stakeholder engagement, medical scientific projects and scientific communications. • Identify, develop and maintain collaborative relationships with KOLs, scientific experts and other medical scientific stakeholders. • Compile, analyze, prepare and deliver high quality medical pharmaceutical and scientific communications in line with defined communication plans. • Create and execute stakeholder engagement plans, according to Sobi’s high standards. • Support country “Global Brand” team in developing local medical tactics and provide input to Headquarter (HQ)/regional plans if relevant • Organize and set up scientific advisory boards with the appropriate key stakeholders, in collaboration with Medical Advisor or Senior Medical Advisor (MA, SMA). • Contribute and support medical scientific aspects in various activities locally and regionally. • Provide local and regional feedback to HQ when performing Business Development Due Diligence. • Deliver inputs to head office led medical programs ahead of launch. • Coordinate Investigator Sponsored Studies (ISSs) as appropriate and support studies on the local level • Coordinate medical information enquiries in collaboration with MA/SMA and HQ in Stockholm. • Attend relevant local, regional and global congresses and symposia to represent Sobi and interact with appropriate stakeholders and customers. • Represent the scientific interests in internal and external forums and interact with KOLs at, e.g., hospitals and other Non-Governmental Organizations within the therapeutic area. • Maintain and develop strong relationships with scientific societies and central decision makers • Provide advice to the organization and management on medical matters and their legal implications. • Safeguard that the medical and scientific knowledge for the therapeutic area remains at the forefront of contemporary thinking; remain updated on therapeutic trends related to new and existing products.

• Serve as the primary field‑based medical and scientific expert for Tryngolza within the sHTG community • Build and maintain strong, trusted relationships with key opinion leaders (KOLs), healthcare professionals, and academic researchers • Conduct non‑promotional scientific discussions on disease pathways, clinical evidence, patient management, and emerging data • Gather and communicate actionable insights from HCP interactions, scientific meetings, and stakeholder activities • Deliver scientific education to HCPs, centers, and relevant networks • Support the Medical Advisor in developing educational content, disease‑awareness programs, and scientific resources • Contribute to evidence‑generation activities including Phase IIIb/IV studies and investigator‑initiated research • Ensure all field activities and materials adhere to internal medical governance standards, SOPs, and external codes of practice

• Participate in the development of and lead the execution of the medical pre-launch and launch activities for an Immunology asset • Manage engagement of global KOLs in the field • Input to clinical development activities • Internal and external medical/scientific communication and education deliverables • Provide scientific input to the development of material driven by cross-functional teams • Execute global medical strategy for an Immunology asset, including build and execute global medical strategy and tactical plans (pre-launch and launch)

• Responsible for Drug Substance (DS) synthesis of a small molecule used in oral dosage forms. • Lead the technical workstreams of manufacturing process transfers from development to commercial site and between commercial sites. • Scale-up activities, process validations and oversee manufacturing of Drug Substance small molecules at external manufacturers for projects in clinical and commercial phase. • Collaborate effectively with external manufacturing partners to oversee all technical drug substance synthesis aspects (GMP and non-GMP steps). • Lead internal activities related to external manufacturing such as process change assessments, major/critical deviations, risk assessments and CAPAs. • Review and supervise design, set up, execution and documentation of DS related technical studies (CMC development as well as commercial operations), process and equipment qualifications and validations. • Write and review applicable sections in registration files, variations and market expansion.